Cargando…

Therapeutic Strategies against Ebola Virus Infection

Since the 2014–2016 epidemic, Ebola virus (EBOV) has spread to several countries and has become a major threat to global health. EBOV is a risk group 4 pathogen, which imposes significant obstacles for the development of countermeasures against the virus. Efforts have been made to develop anti-EBOV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ching-Hsuan, Hu, Yee-Tung, Wong, Shu Hui, Lin, Liang-Tzung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954160/ https://www.ncbi.nlm.nih.gov/pubmed/35336986 http://dx.doi.org/10.3390/v14030579

Ejemplares similares

Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family
por: Wong, Shu Hui, et al.
Publicado: (2019)

Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects
por: Liu, Ching-Hsuan, et al.
Publicado: (2021)

Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
por: Belem, Wendimi Fatimata, et al.
Publicado: (2022)

Ebola virus (EBOV) infection: Therapeutic strategies
por: De Clercq, Erik
Publicado: (2015)

The Methanolic Extract of Perilla frutescens Robustly Restricts Ebola Virus Glycoprotein-Mediated Entry
por: Kuo, Yu-Ting, et al.
Publicado: (2021)

Pandemic strategies with computational and structural biology against COVID-19: A retrospective
por: Liu, Ching-Hsuan, et al.
Publicado: (2021)

Tracing down the updates on Ebola virus surges: An update on anti-ebola therapeutic strategies
por: Malik, Shiza, et al.
Publicado: (2023)

Ebola Virus Entry into Host Cells: Identifying Therapeutic Strategies
por: Rhein, Bethany A., et al.
Publicado: (2015)

In Vivo Activity of Amodiaquine against Ebola Virus Infection
por: DeWald, Lisa Evans, et al.
Publicado: (2019)

Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection
por: Esmagambetov, I. B., et al.
Publicado: (2021)

Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies
por: de Wit, Emmie, et al.
Publicado: (2011)

Possible FDA-approved drugs to treat Ebola virus infection
por: Yuan, Shu
Publicado: (2015)

Contribution of Human Retroviruses to Disease Development—A Focus on the HIV– and HERV–Cancer Relationships and Treatment Strategies
por: Liu, Ching-Hsuan, et al.
Publicado: (2020)

Novel Antiviral Molecules against Ebola Virus Infection
por: Collados Rodríguez, Mila, et al.
Publicado: (2023)

Small molecules with antiviral activity against the Ebola virus
por: Litterman, Nadia, et al.
Publicado: (2015)

Ebola virus disease in nonendemic countries
por: Wong, Samson Sai-Yin, et al.
Publicado: (2015)

A web-based resource for designing therapeutics against Ebola Virus
por: Dhanda, Sandeep Kumar, et al.
Publicado: (2016)

Host Transcriptional Response to Ebola Virus Infection
por: Speranza, Emily, et al.
Publicado: (2017)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
por: Warren, Travis K., et al.
Publicado: (2016)

Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb
por: Qiu, Xiangguo, et al.
Publicado: (2013)

Therapeutic Strategies against Biofilm Infections
por: Mishra, Sonal, et al.
Publicado: (2023)

SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus
por: Muñoz-Basagoiti, Jordana, et al.
Publicado: (2021)

Ebola Virus Infection: Overview and Update on Prevention and Treatment
por: Martínez, Miguel J., et al.
Publicado: (2015)

Pooled Analysis of the Accuracy of Xpert Ebola Assay for Diagnosing Ebola Virus Infection
por: Pan, Zhi-Yong, et al.
Publicado: (2021)

Targeting Autophagy Augments Berberine-Mediated Cell Death in Human Hepatoma Cells Harboring Hepatitis C Virus RNA
por: Tai, Chen-Jei, et al.
Publicado: (2020)

Chemovirotherapeutic Treatment Using Camptothecin Enhances Oncolytic Measles Virus-Mediated Killing of Breast Cancer Cells
por: Tai, Chen-Jei, et al.
Publicado: (2019)

Ebola, the killer virus
por: Ghazanfar, Haider, et al.
Publicado: (2015)

Mechanisms of Immunity in Post-Exposure Vaccination against Ebola Virus Infection
por: Bradfute, Steven B., et al.
Publicado: (2015)

Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection
por: Lane, Thomas R., et al.
Publicado: (2019)

Understanding Ebola Virus Transmission
por: Judson, Seth, et al.
Publicado: (2015)

An overview of Ebola virus disease
por: Kadanali, Ayten, et al.
Publicado: (2015)

Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus
por: Lai, Kang Yiu, et al.
Publicado: (2014)

Ursolic Acid and Its Nanoparticles Are Potentiators of Oncolytic Measles Virotherapy against Breast Cancer Cells
por: Liu, Ching-Hsuan, et al.
Publicado: (2021)

Naturally Occurring Single Mutations in Ebola Virus Observably Impact Infectivity
por: Wong, Gary, et al.
Publicado: (2018)

Methanolic Extract of Rhizoma Coptidis Inhibits the Early Viral Entry Steps of Hepatitis C Virus Infection
por: Hung, Ting-Chun, et al.
Publicado: (2018)

Therapy of Ebola and Marburg virus infections
por: Bray, Mike
Publicado: (2006)

Ebola virus infection induces autoimmunity against dsDNA and HSP60
por: Fausther-Bovendo, H., et al.
Publicado: (2017)

Ebola outbreak in Western Africa 2014: what is going on with Ebola virus?
por: Na, Woonsung, et al.
Publicado: (2015)

Ocular problem in Ebola virus infection: A short review
por: Wiwanitkit, Somsri, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9sck2lsog0pdcv3bh6b2a1odor